Supporting fundraising post-IPO
2025
CASE STUDY
BIOTECHNOLOGY
Trusted by:
... and many others
THE GOAL
CUSTOMER'S Profile
Streamline fundraising among stakeholders. As a public company, Turn Tx needed to build credibility through a consistent brand identity across all assets (pitch deck, website, MoA videos).
Turn Therapeutics is a clinical-stage biotechnology company focused on dermatology, wound care, and infectious disease.
They develop first-in-class topical cytokine-modulating therapeutics designed to deliver targeted anti-inflammatory effects without systemic immune exposure or injections.
- website update
- pitch deck update
- 2 3D MoA videos.
THE DELIVERABLES
4
meetings
Communication with client is essential for us. To listen to them and provide with the best result
6
rounds
Six feedback rounds on the production stage
Claryfying core messages and communication objectives, and references
First drafts of both MoA videos
8
weeks
Duration from the first kick-off meeting to the final delivery of all the materials
Timeline and Process
Presentation of the pitch deck, and website
WEEK 1
WEEK 4
WEEK 6
WEEK 7
WEEK 8
Final Website Version
Final Pitch Deck Design
Website structure finalization
Visual content development for the Website
First draft of the revamped Pitch Deck
Website update
We developed the structure and visual assets for the website
Visualizing complex science
At the core of Turn Therapeutics is PermaFusion, their proprietary drug delivery platform. It enables water-soluble therapeutic agents to penetrate deeper tissue layers without emulsifiers, adjuvants, or unnecessary additives.
This capability allows them to design therapies that deliver meaningful concentrations of active agents in skin, nail, or mucosal tissue, while minimizing off-target exposure.
Turn's Feedback
"Want to thank NANOBOT GROUP for delivering game-changing materials ahead of the J.P. Morgan healthcare conference.
I cannot speak highly enough about longtime friend Yuriy Svidinenko or his team. They crunched keyboards through the holidays and remade our website & deck in record time.
If you haven’t seen the new digs, check em’ out! It’s science front and center over here. MOA’s and RCT’s and IL’s...all the acronyms!"
Bradley Burnam
Founder/CEO Turn Therapeutics
EU & US based,
operating globally since 2016
4.9/5
customer satisfaction
Full Cycle Digital Marketing Agency for Life Science Companies
2010 first scientific videos were developed
We Are Proud Of
15
years of expertise in scientific communications
500+
successful projects
1000+
minutes of scientific video
20 +
highly skilled professionals, 3 PhD level colleagues
100+
pitch decks and sales aids
Our mission:
to help bring 100 Impactful products/ideas to market by 2030 (5 years!).
Clients
and many more....
Winning Hearts and Minds.
Let's talk!
Andrii Koniukh
Co-Founder and CEO
EU •
Yurii Svidinenko
Co-Founder and Production director
US •
Thank you for asking us!
